Quantitative Systematic Strategies’s Clovis Oncology, Inc. CLVS Stock Holding History

Quantitative Systematic Strategies’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,567	Closed	-$208K	–	705
2018 Q4	$208K	Buy	+11,567	New	+$236K	0.05%	515
2017 Q3	–	Sell	-3,466	Closed	-$319K	–	580
2017 Q2	$319K	Sell	3,466 -671	-16%	-$41.1K	0.08%	316
2017 Q1	$263K	Sell	4,137 -930	-18%	-$56.5K	0.07%	282
2016 Q4	$223K	Buy	+5,067	New	+$178K	0.09%	268
2016 Q3	–	Sell	-49,852	Closed	-$751K	–	532
2016 Q2	$751K	Buy	+49,852	New	+$729K	0.35%	136
2016 Q1	–	Sell	-29,721	Closed	-$1.02M	–	839
2015 Q4	$1.02M	Buy	+29,721	New	+$1.92M	0.28%	32
2014 Q4	–	Sell	-11,070	Closed	-$525K	–	447
2014 Q3	$525K	Buy	+11,070	New	+$462K	0.31%	136

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Quantitative Systematic Strategies's CLVS Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Clovis Oncology, Inc. (CLVS) in Q1 2019, closing a stake of 11,567 shares — an estimated $208K sold.

Quantitative Systematic Strategies first reported a position in CLVS in Q3 2014 and held it in 7 quarters. The position peaked at $1.02M in Q4 2015. 186 funds tracked by Wall St. Rank hold CLVS as of Q1 2019.

Quantitative Systematic Strategies reported no remaining Clovis Oncology, Inc. position as of Q1 2019 after selling out during the quarter.
Quantitative Systematic Strategies sold 11,567 Clovis Oncology, Inc. shares in Q1 2019, an estimated $208K.
Quantitative Systematic Strategies first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 7 quarters.
Quantitative Systematic Strategies's Clovis Oncology, Inc. position peaked at $1.02M in Q4 2015.
186 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.